# Advarra

- **Section**: news
- **Answer**: Advarra: 35 headlines on record, 14 headlines in the last 90 days. Its story counts 2 milestones.
- **As of**: 2026-11-17
- **Cite**: Advarra, News. Alion, Nov 17, 2026. https://alion.io/company/advarra/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2414960
- **Name**: Advarra
- **Domain**: advarra.com
- **Url**: <https://alion.io/company/advarra>

## Figures

- Label: Headlines; Value: 35
- Label: In 90 days; Value: 14
- Label: Milestones; Value: 2

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 35
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 2

## News

- [The Path Ahead to Improve DEI in Clinical Trials Applied Clinical Trials Online](https://appliedclinicaltrialsonline.com/view/path-ahead-improve-dei-clinical-trials) — Date: 2026-10-08; Kind: News; Source: clin trials
- [The Latest Advancements in Single Sign-On Technology Applied Clinical Trials Online](https://appliedclinicaltrialsonline.com/view/latest-advancements-single-sign-on-technology) — Date: 2026-10-08; Kind: News; Source: clin trials
- [Using Artificial Intelligence to Manage Clinical Trial Conduct Applied Clinical Trials Online](https://appliedclinicaltrialsonline.com/view/artificial-intelligence-manage-clinical-trial-conduct) — Date: 2026-10-08; Kind: News; Source: clin trials
- [Types of Audits in Clinical Trials](https://advarra.com/blog/types-of-audits-in-clinical-trials/) — Date: 2026-10-06; Kind: Blog
- [Q&A with Advarra's Senior Director of IRB Services Christy Frey](https://advarra.com/blog/qa-with-advarras-senior-director-of-irb-services-christy-frey/) — Date: 2026-10-05; Kind: Blog
- [Advarra Launches Site Identification Technology with Insights Directly from Sites - AOL](https://aol.com/articles/advarra-launches-identification-technology-insights-130000000.html) — Date: 2026-10-01; Kind: News; Source: AOL.com
- [Frequently Asked Questions About Investigator-Initiated Trials (IITs)](https://advarra.com/blog/frequently-asked-questions-about-investigator-initiated-trials-iits/) — Date: 2026-09-29; Kind: Blog
- [2026 DHHS Unified Agenda: Four Areas HRPP and IRB Leaders Should Watch](https://advarra.com/blog/2026-dhhs-unified-agenda-four-areas-hrpp-and-irb-leaders-should-watch/) — Date: 2026-09-28; Kind: Blog
- [2026 DHHS Unified Agenda: What Clinical Operations and Study Startup Teams Should Watch](https://advarra.com/blog/2026-dhhs-unified-agenda-what-clinical-operations-and-study-startup-teams-should-watch/) — Date: 2026-09-28; Kind: Blog
- [2026 DHHS Unified Agenda: What Clinical Research Leaders Need to Know](https://advarra.com/blog/2026-dhhs-unified-agenda-what-clinical-research-leaders-need-to-know/) — Date: 2026-09-28; Kind: Blog
- [The Belmont Report Still Shapes How IRBs Protect Human Research Subjects Today](https://advarra.com/blog/the-belmont-report-still-shapes-how-irbs-protect-human-research-subjects-today/) — Date: 2026-09-28; Kind: Blog
- [A Better SIV Model Starts by Separating the Common from the Unique](https://advarra.com/blog/a-better-siv-model-starts-by-separating-the-common-from-the-unique/) — Date: 2026-09-24; Kind: Blog
- [NHSR, Exempt, Expedited, or Full Board? A Plain-Language Guide to Potential Review Pathways](https://advarra.com/blog/nhsr-exempt-expedited-or-full-board-a-plain-language-guide-to-potential-review-pathways/) — Date: 2026-09-11; Kind: Blog
- [Using Longitudinal Endpoint Data to Anticipate Study Complexity](https://advarra.com/blog/using-longitudinal-endpoint-data-to-anticipate-study-complexity/) — Date: 2026-09-10; Kind: Blog
- [Advarra and IgniteData team up for secure trial data transfer](https://yahoo.com/news/articles/advarra-ignitedata-team-secure-trial-121953142.html) — Date: 2025-11-13; Kind: News; Source: Yahoo News
- [Advarra Expands Its Study Collaboration Solution with Novel Site-Centered Technology to Improve Study Startup](https://prnewswire.com/news-releases/advarra-expands-its-study-collaboration-solution-with-novel-site-centered-technology-to-improve-study-startup-302522631.html) — Date: 2025-08-06; Kind: Press release; Source: PRNewswire
- [Site Survival: Why Clinical Research Sites Need a Lifeline](https://biospace.com/drug-development/site-survival-why-clinical-research-sites-need-a-lifeline) — Date: 2025-02-19; Kind: News; Source: BioSpace
- [Advarra introduces Study Collaboration to help improve trial partnership](https://finance.yahoo.com/news/advarra-introduces-study-collaboration-help-120505841.html) — Date: 2025-01-22; Kind: News; Source: YahooFinance
- [New Predictions for 2025](https://globalforum.diaglobal.org/issue/january-2025/additional-predictions-for-2025/) — Date: 2025-01-08; Kind: News; Source: DIA Global Forum
- [The EU AI Regulation: Transforming Clinical Research Through Regulation](https://globalforum.diaglobal.org/issue/january-2025/the-eu-ai-regulation-transforming-clinical-research-through-regulation/) — Date: 2025-01-08; Kind: News; Source: DIA Global Forum
- [Opinion: A Cautiously Sunny Outlook for Biopharma in 2025](https://biospace.com/business/opinion-a-cautiously-sunny-outlook-for-biopharma-in-2025) — Date: 2025-01-08; Kind: News; Source: BioSpace
- [Advarra Announces Recent Cybersecurity Incident Leading to Data Breach that Leaked Consumers' SSNs](https://jdsupra.com/legalnews/advarra-announces-recent-cybersecurity-6736040/) — Date: 2023-12-21; Kind: News; Source: jdsupra.com
- [Advarra Acquires Bio-Optronics, Maker of Clinical Conductor TrialSuite Newswise](https://newswise.com/articles/advarra-acquires-bio-optronics-maker-of-clinical-conductor-trialsuite) — Date: 2021-03-09; Kind: News; Source: newswise.com
- [Advarra Acquires YourEncore, a Leading Provider of Drug Development and Commercialization Advisory and Consulting Services](https://streetinsider.com/PRNewswire/Advarra+Acquires+YourEncore%2C+a+Leading+Provider+of+Drug+Development+and+Commercialization+Advisory+and+Consulting+Services/17795276.html) — Date: 2021-01-07; Kind: Press release; Source: streetinsider.com
- [Advarra Acquires IRBco](https://prnewswire.com/news-releases/advarra-acquires-irbco-301043101.html) — Date: 2020-04-20; Kind: Press release; Source: PRNewswire
- [Gene Therapy Successes in Ophthalmology](https://themedicinemaker.com/issues/2025/articles/jun/gene-therapy-successes-in-ophthalmology/) — Kind: News; Source: The Medicine Maker
- [Clinical Trials Get A Council For AI Oversight](https://clinicalleader.com/doc/clinical-trials-get-a-council-for-ai-oversight-0001) — Kind: News; Source: EdClinical
- [In the News The Broken Site Feasibility Process Could CROs Be the Fixers? Advarras Christine Senn discusses compelling data from a recent site feasibility survey, the opportunity for… Read more](https://contractpharma.com/exclusives/the-broken-site-feasibility-process-could-cros-be-the-fixers/) — Kind: News; Source: contractpharma.com
- [In the News Navigating AI in Clinical Trials: Insights from Advarra's Laura Russell Advarra has launched the Council for Responsible AI in Clinical Trials to ensure the ethical… Read more](https://clinicaltrialvanguard.com/executiveinterviews/navigating-ai-in-clinical-trials-insights-from-advarras-laura-russell/) — Kind: News; Source: clinicaltrialvanguard.com
- [In the News AMR Deploys Advarra's Site Training and Engagement Platform See this staff-written news brief highlighting AMRs selection of Longboat. Read more](https://contractpharma.com/contents/view_breaking-news/2024-10-30/amr-deploys-advarras-site-training-and-engagement-platform/?widget=listSection) — Kind: News; Source: contractpharma.com
- [In the News 2025 Trends Buoying Boom Phase in APAC This staff-written feature article discusses the predictions for 2025 from industry leaders, including Advarras Jeff… Read more](https://biospectrumasia.com/analysis/25/25270/2025-trends-buoying-boom-phase-in-apac.html) — Kind: News; Source: biospectrumasia.com
- [In the News PRIM&R Launches Educational Initiative to Advance Ethical AI Governance in Research with Grant from Advarra New programming will equip research oversight professionals with independent education, leadership dialogue, and practical resources… Read more](https://primr.org/press-room/primrs-ai-ethics-and-governance-initiative/) — Kind: News; Source: primr.org
- [In the News Why Data Monitoring Committees are Crucial in Multi-Regional Oncology Trials Check out this informative read about the importance of Data Monitoring Committees in multi-site oncology… Read more](https://calameo.com/read/006113385fa22f16c254f?page=32) — Kind: News; Source: calameo.com
- [In the News Beyond the Breakthrough: Navigating the realities of CAR-T cell oncology trials Beyond the Breakthrough explores the challenges of CAR-T oncology trials, from complex logistics and safety… Read more](https://nxtbook.com/comparenetworks/CellGeneTherapyReview/cell-gene-therapy-review-q3-2025/index.php?aid=620643&amp;catid=27278&amp;s=1&amp;ctid=2&amp;liap=true&amp;lids=1266599&amp;fid=2470&amp;alfp=True&amp;ppim=&amp;ltid=2186) — Kind: News; Source: nxtbook.com
- [The "One-and-Done" PI & Measuring the Current Site Landscape](https://clinicalleader.com/doc/the-one-and-done-pi-measuring-the-current-site-landscape-0001) — Kind: News; Source: EdClinical

## Story

- [Acquisition Advarra Acquires YourEncore, a Leading Provider of Drug Development and Commercialization Advisory and Consulting Services · streetinsider.com](https://streetinsider.com/PRNewswire/Advarra+Acquires+YourEncore%2C+a+Leading+Provider+of+Drug+Development+and+Commercialization+Advisory+and+Consulting+Services/17795276.html)
- [Acquisition Advarra Acquires IRBco · PRNewswire](https://prnewswire.com/news-releases/advarra-acquires-irbco-301043101.html)

---
[Page](https://alion.io/company/advarra/news) · [JSON](https://alion.io/company/advarra/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
